Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.

Facon T, Kumar S, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O'Dwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje N, Attal M, Tiab M, Macro M, Frenzel L, Leleu X, Ahmadi T, Chiu C, Wang J, Van Rampelbergh R, Uhlar CM, Kobos R, Qi M, Usmani SZ; MAIA Trial Investigators.

N Engl J Med. 2019 May 30;380(22):2104-2115. doi: 10.1056/NEJMoa1817249.

PMID:
31141632
2.

Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis.

Ortiz MV, Fernandez-Ledon S, Ramaswamy K, Forlenza CJ, Shukla NN, Kobos R, Heaton TE, LaQuaglia MP, Steinherz PG.

Pediatr Blood Cancer. 2019 Jan;66(1):e27500. doi: 10.1002/pbc.27500. Epub 2018 Oct 18.

PMID:
30334607
3.

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.

Giulino-Roth L, O'Donohue T, Chen Z, Trippett TM, Klein E, Kernan NA, Kobos R, Prockop SE, Scaradavou A, Shukla N, Steinherz PG, Moskowitz AJ, Moskowitz CH, Boulad F.

Leuk Lymphoma. 2018 Aug;59(8):1861-1870. doi: 10.1080/10428194.2017.1403601. Epub 2017 Nov 29.

PMID:
29183202
4.

Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.

Yan SQ, Seyboth B, Kobos R, Eaton A, Seo SK, Cohen N.

J Pediatric Infect Dis Soc. 2018 May 15;7(2):169-171. doi: 10.1093/jpids/pix022.

5.

Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients.

Liu D, Seyboth B, Mathew S, Gilheeney SW, Chou AJ, Drill E, Kobos R.

J Pediatr Hematol Oncol. 2017 May;39(4):e177-e182. doi: 10.1097/MPH.0000000000000791.

PMID:
28234746
6.

Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.

Sait S, Kobos R, LaQuaglia MP, Pandit-Taskar N, Modak S.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26314. Epub 2016 Nov 2.

7.

Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors.

Mussetti A, Kernan NA, Prockop SE, Scaradavou A, Lehrman R, Ruggiero JM, Curran K, Kobos R, O'Reilly R, Boulad F.

Pediatr Hematol Oncol. 2016 Sep;33(6):347-358. Epub 2016 Oct 7.

8.

Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors.

Shukla N, Somwar R, Smith RS, Ambati S, Munoz S, Merchant M, D'Arcy P, Wang X, Kobos R, Antczak C, Bhinder B, Shum D, Radu C, Yang G, Taylor BS, Ng CK, Weigelt B, Khodos I, de Stanchina E, Reis-Filho JS, Ouerfelli O, Linder S, Djaballah H, Ladanyi M.

Cancer Res. 2016 Aug 1;76(15):4525-34. doi: 10.1158/0008-5472.CAN-16-1040. Epub 2016 Jun 2.

9.

Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa.

Spitzer B, Perales MA, Kernan NA, Prockop SE, Zabor EC, Webb N, Castro-Malaspina H, Papadopoulos EB, Young JW, Scaradavou A, Kobos R, Giralt SA, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1449-1454. doi: 10.1016/j.bbmt.2016.05.001. Epub 2016 May 13.

10.

Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.

Ortiz MV, Kobos R, Walsh M, Slotkin EK, Roberts S, Berger MF, Hameed M, Solit D, Ladanyi M, Shukla N, Kentsis A.

Pediatr Blood Cancer. 2016 Aug;63(8):1368-74. doi: 10.1002/pbc.26002. Epub 2016 Apr 15.

11.

Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

Anur P, Friedman DN, Sklar C, Oeffinger K, Castiel M, Kearney J, Singh B, Prockop SE, Kernan NA, Scaradavou A, Kobos R, Curran K, Ruggiero J, Zakak N, O'Reilly RJ, Boulad F.

Bone Marrow Transplant. 2016 Jul;51(7):938-44. doi: 10.1038/bmt.2016.32. Epub 2016 Mar 21.

12.

Advances in therapies for non-Hodgkin lymphoma in children.

Kobos R, Terry W.

Hematology Am Soc Hematol Educ Program. 2015;2015:522-8. doi: 10.1182/asheducation-2015.1.522. Review.

PMID:
26637768
13.

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.

Moskowitz AJ, Schöder H, Yahalom J, McCall SJ, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz S, Kobos R, Kumar A, Matasar M, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Shukla N, Steinherz P, Straus D, Trippett T, Younes A, Zelenetz A, Moskowitz CH.

Lancet Oncol. 2015 Mar;16(3):284-92. doi: 10.1016/S1470-2045(15)70013-6. Epub 2015 Feb 13.

PMID:
25683846
14.

Prognostic factors in fibrolamellar hepatocellular carcinoma in young people.

Darcy DG, Malek MM, Kobos R, Klimstra DS, DeMatteo R, La Quaglia MP.

J Pediatr Surg. 2015 Jan;50(1):153-6. doi: 10.1016/j.jpedsurg.2014.10.039. Epub 2014 Dec 10.

15.

High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children.

Kobos R, Shukla N, Renaud T, Prockop SE, Boulad F, Steinherz PG.

J Pediatr Hematol Oncol. 2014 Jul;36(5):e265-70. doi: 10.1097/MPH.0000000000000080.

PMID:
24327129
16.

Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.

Shukla N, Kobos R, Renaud T, Steinherz LJ, Steinherz PG.

Pediatr Blood Cancer. 2014 Mar;61(3):431-5. doi: 10.1002/pbc.24789. Epub 2013 Sep 24.

PMID:
24115731
17.

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.

Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M.

Sci Transl Med. 2013 Mar 20;5(177):177ra38. doi: 10.1126/scitranslmed.3005930.

18.

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.

Kobos R, Nagai M, Tsuda M, Merl MY, Saito T, Laé M, Mo Q, Olshen A, Lianoglou S, Leslie C, Ostrovnaya I, Antczak C, Djaballah H, Ladanyi M.

J Pathol. 2013 Apr;229(5):743-754. doi: 10.1002/path.4158. Epub 2013 Mar 5.

19.

Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.

Bohn OL, Whitten J, Spitzer B, Kobos R, Prockop S, Boulad F, Arcila M, Wang L, Teruya-Feldstein J.

Int J Surg Pathol. 2013 Oct;21(5):520-5. doi: 10.1177/1066896912468214. Epub 2012 Dec 5.

PMID:
23222806
20.

Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.

Honeyman JN, Rich BS, McEvoy MP, Knowles MA, Heller G, Riachy E, Kobos R, Shukla N, Wolden SL, Steinherz PG, La Quaglia MP.

J Pediatr Surg. 2012 Jun;47(6):1228-33. doi: 10.1016/j.jpedsurg.2012.03.030. Review.

PMID:
22703798
21.

Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.

Shukla N, Kobos R, Renaud T, Teruya-Feldstein J, Price A, McAllister-Lucas L, Steinherz P.

Cancer. 2012 Aug 1;118(15):3719-24. doi: 10.1002/cncr.26712. Epub 2011 Dec 13.

22.

Paroxysmal nocturnal hemoglobinuria in pediatric patients.

Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Small TN, Kobos R, Castro-Malaspina H, Araten D, DiMichele D, O'Reilly RJ, Boulad F.

Pediatr Blood Cancer. 2012 Sep;59(3):525-9. doi: 10.1002/pbc.23410. Epub 2011 Dec 6.

PMID:
22147651
23.

Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.

Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80. doi: 10.1016/j.bbmt.2011.11.009. Epub 2011 Nov 10.

24.

Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT).

Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R, Knowles MA, Papadopoulos EB, Casson A, Copeland C, Torok-Castanza J, Zakak N, Ruggiero J, Small TN.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1708-13. doi: 10.1016/j.bbmt.2011.05.006. Epub 2011 May 23.

25.

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

Ponce DM, Zheng J, Gonzales AM, Lubin M, Heller G, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq RR, Koehne G, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, Kernan NA, Kobos R, Prockop S, Scaradavou A, Small T, O'Reilly RJ, Barker JN.

Biol Blood Marrow Transplant. 2011 Sep;17(9):1316-26. doi: 10.1016/j.bbmt.2011.01.006. Epub 2011 Jan 11.

26.

Effect of hemodialysis on the plasma levels of clofarabine.

Steinherz PG, Shukla N, Kobos R, Latcha S.

Pediatr Blood Cancer. 2010 Jul 15;55(1):196-8. doi: 10.1002/pbc.22458.

PMID:
20232428
27.

Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.

Steinherz PG, Shukla N, Kobos R, Steinherz L.

Pediatr Blood Cancer. 2010 May;54(5):687-93. doi: 10.1002/pbc.22321.

PMID:
20205253
28.

Overview of thrombopoietic agents in the treatment of thrombocytopenia.

Kobos R, Bussel JB.

Clin Lymphoma Myeloma. 2008 Feb;8(1):33-43. doi: 10.3816/CLM.2008.n.002. Review.

PMID:
18501086
29.

Jaundice in the adult patient.

Roche SP, Kobos R.

Am Fam Physician. 2004 Jan 15;69(2):299-304. Review.

30.

Separation of double-stranded DNA fragments in plastic capillary electrophoresis chips by using E99P69E99 as separation medium.

Song L, Fang D, Kobos RK, Pace SJ, Chu B.

Electrophoresis. 1999 Oct;20(14):2847-55.

PMID:
10546819
31.

Enhancement of enzyme-activated 1,2-dioxetane chemiluminescence in membrane-based assays.

Kobos RK, Blue BA, Robertson CW, Kielhorn LA.

Anal Biochem. 1995 Jan 1;224(1):128-33.

PMID:
7710059
32.

Immobilization of perfluoroalkylated enzymes in a biologically active state onto Perflex support.

Boivin P, Kobos RK, Papa SL, Scouten WH.

Biotechnol Appl Biochem. 1991 Oct;14(2):155-69.

PMID:
1760128
33.
34.

Electrochemical determination of hemoglobin, hematocrit, and hemolysis.

Kobos RK, Abbott SD, Levin HW, Kilkson H, Peterson DR, Dickinson JW.

Clin Chem. 1987 Jan;33(1):153-8.

35.

Enzyme-based electrochemical sensors.

Kobos RK.

ASAIO Trans. 1986 Oct-Dec;32(2):701-5. No abstract available.

PMID:
3801232
36.

Potentiometric microbiological assay of gentamicin, streptomycin, and neomycin with a carbon dioxide gas-sensing electrode.

Simpson DL, Kobos RK.

Anal Chem. 1983 Oct;55(12):1974-7. No abstract available.

PMID:
6416110
37.

Glutamine-selective membrane electrode that uses living bacterial cells.

Rechnitz GA, Riechel TL, Kobos RK, Meyerhoff ME.

Science. 1978 Jan 27;199(4327):440-1.

PMID:
619467
38.

A bio-selective membrane electrode prepared with living bacterial cells.

Rechnitz GA, Kobos RK, Riechel SJ, Gebauer CR.

Anal Chim Acta. 1977 Dec 1;94(2):357-65. No abstract available.

PMID:
413457
39.

Acetylcholine-ATP binding by direct membrane electrode measurement.

Kobos RK, Rechnitz GA.

Biochem Biophys Res Commun. 1976 Aug 9;71(3):762-7. No abstract available.

PMID:
9084
40.

Thermodynamics of AMP reactions from membrane electrode measurements of metal ion complexation.

Kobos RK, Rechnitz GA.

Arch Biochem Biophys. 1976 Jul;175(1):11-20. No abstract available.

PMID:
952511

Supplemental Content

Support Center